EquityZen Growth Technology Fund LLC - Series 1572
Raised
$276K
Investors
19
Min Invest
$5,016
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1572 is a Delaware pooled investment fund filed by EquityZen Advisors LLC on 2023-01-25, raising $276K from 19 investors under Rule 506(b) and Section 3(c)(1) exemptions. The fund maintains a $5K minimum investment and is part of EquityZen's pre-IPO secondary market platform, which operates nearly 1,900 series vehicles providing retail-accessible exposure to private growth companies.
This pre-IPO pooled fund uses the standard 506(b)/3(c)(1) structure typical of EquityZen's series vehicle approach, with a $5K minimum positioning it at the retail-accessible end of the private investment spectrum. The small per-investor average of approximately $14.5K reflects EquityZen's model of aggregating numerous small checks into concentrated positions in single late-stage private companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Eric Bernstein
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
